Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Basic information of adverse event reports related to kidney injury from cyclosporine and tacrolimus

From: A comparative analysis of drug-induced kidney injury adverse reactions between cyclosporine and tacrolimus based on the FAERS database

 

Number of Reports/Instances

Report Percentage/%

Number of Reports/Instances

Report Percentage/%

Cyclosporine

Tacrolimus

Sex

 Male

1290

37.40%

2084

37.63%

 Female

1808

52.42%

2967

53.58%

 Unknown

351

10.18%

487

8.79%

Weight

 < 50 kg

177

5.13%

254

4.59%

 50 ~ 100 kg

544

15.77%

739

13.34%

 > 100 kg

49

1.42%

80

1.44%

 Unknown

2679

77.67%

4465

80.62%

Age (Years)

 < 18

337

9.77%

428

7.73%

 18 ~ 28

193

5.60%

331

5.98%

 28 ~ 38

311

9.02%

501

9.05%

 38 ~ 48

379

10.99%

670

12.10%

 48 ~ 58

517

14.99%

1110

20.04%

 58 ~ 68

503

14.58%

1061

19.16%

 68 ~ 78

304

8.81%

520

9.39%

 78 ~ 88

95

2.75%

77

1.39%

 ≥ 88

12

0.35%

1

0.02%

 Unknown

798

23.14%

839

15.15%

Reporter

 Consumer

273

7.92%

943

17.03%

 Healthcare Professional

2887

83.71%

4448

80.32%

 Unknown

289

8.38%

147

2.65%